Antigen peptide transporter 1 is involved in the development of fructose-induced hepatic steatosis in mice. 2013

Shailendra Arindkar, and Jashdeep Bhattacharjee, and Jerald Mahesh Kumar, and Barun Das, and Pramod Upadhyay, and Shajahan Asif, and Ramesh C Juyal, and Subeer S Majumdar, and Nagarajan Perumal
National Institute of Immunology, New Delhi, India.

OBJECTIVE The purpose of this study is to assess whether the decrease in CD8 cells has any role in the development of non-alcoholic fatty liver disease (NAFLD). In this study, we therefore used antigen peptide transporter 1 (TAP1(-/-)) mice that cannot transport major histocompatibility complex class I antigens onto the cell surface resulting in failure of the generation of CD8 cells. METHODS Wild-type C57Bl/6J and TAP1(-/-) mice were fed with 30% fructose solution for 8 weeks. The percentage of CD4, CD8 cells in peripheral blood mononuclear cells, and liver were sorted by fluorescence-activated cell sorting in both control and fructose-treated mice. Bodyweight, histopathological changes, oil red O staining, glucose tolerance test, intraperitoneal insulin tolerance test, serum levels of triglycerides, cholesterol, aspartate aminotransferase, and alanine aminotransferase were also evaluated. Quantitative real-time polymerase chain reaction was performed to determine the expression of specific genes involved in development of fatty changes in the liver. RESULTS Chronic consumption of fructose in TAP1(-/-) mice did not develop NAFLD, insulin resistance, or change in level of CD8 cells. Moreover, there was delay in relative expression levels of genes involved in development of NAFLD in fructose-treated TAP1(-/-) mice. CONCLUSIONS Taken together, the data suggest that TAP1(-/-) -deficient mice displayed reduced levels of CD8 cells that have a vital role in the initiation and propagation of liver inflammation and is a casual role in the beginning of fructose-induced liver damage as well as insulin resistance in mice.

UI MeSH Term Description Entries
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005234 Fatty Liver Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS. Liver Steatosis,Steatohepatitis,Steatosis of Liver,Visceral Steatosis,Liver Steatoses,Liver, Fatty,Steatohepatitides,Steatoses, Liver,Steatoses, Visceral,Steatosis, Liver,Steatosis, Visceral,Visceral Steatoses
D005632 Fructose A monosaccharide in sweet fruits and honey that is soluble in water, alcohol, or ether. It is used as a preservative and an intravenous infusion in parenteral feeding. Levulose,Apir Levulosa,Fleboplast Levulosa,Levulosa,Levulosa Baxter,Levulosa Braun,Levulosa Grifols,Levulosa Ibys,Levulosa Ife,Levulosa Mein,Levulosado Bieffe Medit,Levulosado Braun,Levulosado Vitulia,Plast Apyr Levulosa Mein,Levulosa, Apir,Levulosa, Fleboplast
D000071181 ATP Binding Cassette Transporter, Subfamily B, Member 2 An ATP-binding cassette, sub-family B protein (ATP BINDING CASSETTE TRANSPORTER, SUBFAMILY B) that functions in the transport of ANTIGENS from the CYTOPLASM to the ENDOPLASMIC RETICULUM for association with HISTOCOMPATIBILITY ANTIGENS CLASS I peptides. It also acts as a molecular scaffold for the final stage of MHC class I PROTEIN FOLDING. ABCB2 Protein,ATP Binding Cassette Transporter, Sub-Family B, Member 2,ATP-Binding Cassette Sub-Family B Member 2,Antigen Peptide Transporter-1,Peptide Transporter PSF1,Peptide Transporter TAP1,RING4 Protein,Really Interesting New Gene 4 Protein,TAP-1 Protein,TAP1 Protein,Transporter 1, ATP-Binding Cassette, Sub-Family B (MDR-TAP),ATP Binding Cassette Sub Family B Member 2,Antigen Peptide Transporter 1,PSF1, Peptide Transporter,TAP 1 Protein,TAP1, Peptide Transporter
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012996 Solutions The homogeneous mixtures formed by the mixing of a solid, liquid, or gaseous substance (solute) with a liquid (the solvent), from which the dissolved substances can be recovered by physical processes. (From Grant & Hackh's Chemical Dictionary, 5th ed) Solution
D015395 Histocompatibility Antigens Class I Membrane glycoproteins consisting of an alpha subunit and a BETA 2-MICROGLOBULIN beta subunit. In humans, highly polymorphic genes on CHROMOSOME 6 encode the alpha subunits of class I antigens and play an important role in determining the serological specificity of the surface antigen. Class I antigens are found on most nucleated cells and are generally detected by their reactivity with alloantisera. These antigens are recognized during GRAFT REJECTION and restrict cell-mediated lysis of virus-infected cells. Class I Antigen,Class I Antigens,Class I Histocompatibility Antigen,Class I MHC Protein,Class I Major Histocompatibility Antigen,MHC Class I Molecule,MHC-I Peptide,Class I Histocompatibility Antigens,Class I Human Antigens,Class I MHC Proteins,Class I Major Histocompatibility Antigens,Class I Major Histocompatibility Molecules,Human Class I Antigens,MHC Class I Molecules,MHC-I Molecules,MHC-I Peptides,Antigen, Class I,Antigens, Class I,I Antigen, Class,MHC I Molecules,MHC I Peptide,MHC I Peptides,Molecules, MHC-I,Peptide, MHC-I,Peptides, MHC-I

Related Publications

Shailendra Arindkar, and Jashdeep Bhattacharjee, and Jerald Mahesh Kumar, and Barun Das, and Pramod Upadhyay, and Shajahan Asif, and Ramesh C Juyal, and Subeer S Majumdar, and Nagarajan Perumal
October 2009, Hepatology (Baltimore, Md.),
Shailendra Arindkar, and Jashdeep Bhattacharjee, and Jerald Mahesh Kumar, and Barun Das, and Pramod Upadhyay, and Shajahan Asif, and Ramesh C Juyal, and Subeer S Majumdar, and Nagarajan Perumal
March 2010, American journal of physiology. Gastrointestinal and liver physiology,
Shailendra Arindkar, and Jashdeep Bhattacharjee, and Jerald Mahesh Kumar, and Barun Das, and Pramod Upadhyay, and Shajahan Asif, and Ramesh C Juyal, and Subeer S Majumdar, and Nagarajan Perumal
June 2023, Metabolism: clinical and experimental,
Shailendra Arindkar, and Jashdeep Bhattacharjee, and Jerald Mahesh Kumar, and Barun Das, and Pramod Upadhyay, and Shajahan Asif, and Ramesh C Juyal, and Subeer S Majumdar, and Nagarajan Perumal
December 2010, Journal of lipid research,
Shailendra Arindkar, and Jashdeep Bhattacharjee, and Jerald Mahesh Kumar, and Barun Das, and Pramod Upadhyay, and Shajahan Asif, and Ramesh C Juyal, and Subeer S Majumdar, and Nagarajan Perumal
November 2015, Journal of clinical biochemistry and nutrition,
Shailendra Arindkar, and Jashdeep Bhattacharjee, and Jerald Mahesh Kumar, and Barun Das, and Pramod Upadhyay, and Shajahan Asif, and Ramesh C Juyal, and Subeer S Majumdar, and Nagarajan Perumal
January 2018, Annals of hepatology,
Shailendra Arindkar, and Jashdeep Bhattacharjee, and Jerald Mahesh Kumar, and Barun Das, and Pramod Upadhyay, and Shajahan Asif, and Ramesh C Juyal, and Subeer S Majumdar, and Nagarajan Perumal
June 2012, The British journal of nutrition,
Shailendra Arindkar, and Jashdeep Bhattacharjee, and Jerald Mahesh Kumar, and Barun Das, and Pramod Upadhyay, and Shajahan Asif, and Ramesh C Juyal, and Subeer S Majumdar, and Nagarajan Perumal
November 2016, Journal of molecular endocrinology,
Shailendra Arindkar, and Jashdeep Bhattacharjee, and Jerald Mahesh Kumar, and Barun Das, and Pramod Upadhyay, and Shajahan Asif, and Ramesh C Juyal, and Subeer S Majumdar, and Nagarajan Perumal
November 2017, Journal of molecular endocrinology,
Shailendra Arindkar, and Jashdeep Bhattacharjee, and Jerald Mahesh Kumar, and Barun Das, and Pramod Upadhyay, and Shajahan Asif, and Ramesh C Juyal, and Subeer S Majumdar, and Nagarajan Perumal
January 2024, Biochimica et biophysica acta. Molecular cell research,
Copied contents to your clipboard!